HEADER IMMUNE SYSTEM 20-MAR-07 2UWE TITLE LARGE CDR3A LOOP ALTERATION AS A FUNCTION OF MHC MUTATION COMPND MOL_ID: 1; COMPND 2 MOLECULE: HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA CHAIN; COMPND 3 CHAIN: A, H; COMPND 4 FRAGMENT: ECTO-DOMAIN, RESIDUES 25-299; COMPND 5 SYNONYM: HLA-A201, MHC CLASS I ANTIGEN A*2; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES; COMPND 8 OTHER_DETAILS: MUTATION OF HLA-A2.1 AT POSITION 163, THREONINE TO COMPND 9 ALANINE; COMPND 10 MOL_ID: 2; COMPND 11 MOLECULE: BETA-2-MICROGLOBULIN; COMPND 12 CHAIN: B, I; COMPND 13 FRAGMENT: RESIDUES 21-119; COMPND 14 ENGINEERED: YES; COMPND 15 OTHER_DETAILS: HAS EXTRA METHIONINE DUE TO ESCHERICHIA COLI COMPND 16 EXPRESSION; COMPND 17 MOL_ID: 3; COMPND 18 MOLECULE: UNCHARACTERIZED PROTEIN C15ORF24; COMPND 19 CHAIN: C, J; COMPND 20 FRAGMENT: RESIDUES 4-12; COMPND 21 SYNONYM: SELF-PEPTIDE, P1049; COMPND 22 ENGINEERED: YES; COMPND 23 OTHER_DETAILS: SELF-PEPTIDE RECOGNIZED BY AHIII T CELL WHEN PRESENTED COMPND 24 BY HLA-A2.1.; COMPND 25 MOL_ID: 4; COMPND 26 MOLECULE: AHIII TCR ALPHA CHAIN; COMPND 27 CHAIN: E, L; COMPND 28 ENGINEERED: YES; COMPND 29 MOL_ID: 5; COMPND 30 MOLECULE: AHIII TCR BETA CHAIN; COMPND 31 CHAIN: F, M; COMPND 32 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 VARIANT: T163A; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 9 EXPRESSION_SYSTEM_VARIANT: RIL; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PLM1; SOURCE 11 MOL_ID: 2; SOURCE 12 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 13 ORGANISM_COMMON: HUMAN; SOURCE 14 ORGANISM_TAXID: 9606; SOURCE 15 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 16 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 17 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 18 EXPRESSION_SYSTEM_VARIANT: RIL; SOURCE 19 EXPRESSION_SYSTEM_PLASMID: PHN1; SOURCE 20 MOL_ID: 3; SOURCE 21 SYNTHETIC: YES; SOURCE 22 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 23 ORGANISM_COMMON: HUMAN; SOURCE 24 ORGANISM_TAXID: 9606; SOURCE 25 MOL_ID: 4; SOURCE 26 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 27 ORGANISM_COMMON: MOUSE; SOURCE 28 ORGANISM_TAXID: 10090; SOURCE 29 STRAIN: B6; SOURCE 30 CELL_LINE: AHIII T CELL CLONE; SOURCE 31 CELL: T CELL; SOURCE 32 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 33 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 34 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 35 EXPRESSION_SYSTEM_VARIANT: RIL; SOURCE 36 EXPRESSION_SYSTEM_PLASMID: PLM1; SOURCE 37 MOL_ID: 5; SOURCE 38 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 39 ORGANISM_COMMON: MOUSE; SOURCE 40 ORGANISM_TAXID: 10090; SOURCE 41 STRAIN: B6; SOURCE 42 CELL_LINE: AHIII T CELL CLONE; SOURCE 43 CELL: T CELL; SOURCE 44 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 45 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 46 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 47 EXPRESSION_SYSTEM_VARIANT: RIL; SOURCE 48 EXPRESSION_SYSTEM_PLASMID: PLM1 KEYWDS HOST-VIRUS INTERACTION, PYRROLIDONE CARBOXYLIC ACID, GLYCOPROTEIN, KEYWDS 2 TRANSMEMBRANE, IMMUNE SYSTEM, MHC I, MEMBRANE, RECEPTOR, CLASS I KEYWDS 3 MHC, HYPOTHETICAL PROTEIN, IMMUNOGLOBULIN DOMAIN, IMMUNOGLOBULIN, KEYWDS 4 IMMUNE RESPONSE, TCR-PMHC COMPLEX, T CELL SIGNALING, DISEASE KEYWDS 5 MUTATION EXPDTA X-RAY DIFFRACTION AUTHOR P.J.MILLER,Y.PAZY,B.CONTI,D.RIDDLE,W.E.BIDDISON,E.APPELLA,E.J.COLLINS REVDAT 6 13-DEC-23 2UWE 1 REMARK REVDAT 5 13-JUL-11 2UWE 1 VERSN REVDAT 4 09-JUN-09 2UWE 1 KEYWDS REMARK REVDAT 3 24-FEB-09 2UWE 1 VERSN REVDAT 2 09-OCT-07 2UWE 1 JRNL REVDAT 1 25-SEP-07 2UWE 0 JRNL AUTH P.J.MILLER,Y.PAZY,B.CONTI,D.RIDDLE,E.APPELLA,E.J.COLLINS JRNL TITL SINGLE MHC MUTATION ELIMINATES ENTHALPY ASSOCIATED WITH T JRNL TITL 2 CELL RECEPTOR BINDING. JRNL REF J.MOL.BIOL. V. 373 315 2007 JRNL REFN ISSN 0022-2836 JRNL PMID 17825839 JRNL DOI 10.1016/J.JMB.2007.07.028 REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 121.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 84.8 REMARK 3 NUMBER OF REFLECTIONS : 59694 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.243 REMARK 3 R VALUE (WORKING SET) : 0.240 REMARK 3 FREE R VALUE : 0.290 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 3142 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.40 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.46 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3469 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 67.23 REMARK 3 BIN R VALUE (WORKING SET) : 0.3380 REMARK 3 BIN FREE R VALUE SET COUNT : 187 REMARK 3 BIN FREE R VALUE : 0.4190 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 13140 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 210 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 36.94 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.59000 REMARK 3 B22 (A**2) : 0.86000 REMARK 3 B33 (A**2) : -1.43000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.28000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.846 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.351 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.250 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 21.998 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.931 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.898 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 13324 ; 0.006 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 18109 ; 1.040 ; 1.929 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 1603 ; 5.117 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 647 ;32.832 ;23.570 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 2137 ;13.284 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 82 ;14.417 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 1911 ; 0.058 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 10330 ; 0.002 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 5008 ; 0.161 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 8751 ; 0.292 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 543 ; 0.109 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 88 ; 0.277 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 9 ; 0.192 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 8329 ; 0.301 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 13001 ; 0.377 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 5880 ; 0.535 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 5108 ; 0.790 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 10 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 2 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 1 A 183 REMARK 3 RESIDUE RANGE : C 1 C 9 REMARK 3 ORIGIN FOR THE GROUP (A): 15.9790 -1.8240 19.6630 REMARK 3 T TENSOR REMARK 3 T11: -0.1775 T22: -0.1835 REMARK 3 T33: -0.2189 T12: 0.0412 REMARK 3 T13: 0.0472 T23: 0.0453 REMARK 3 L TENSOR REMARK 3 L11: 2.0116 L22: 3.3261 REMARK 3 L33: 2.2822 L12: 0.5188 REMARK 3 L13: 0.1495 L23: 0.8037 REMARK 3 S TENSOR REMARK 3 S11: 0.0646 S12: -0.0798 S13: -0.0825 REMARK 3 S21: -0.0878 S22: -0.0243 S23: -0.0029 REMARK 3 S31: 0.0247 S32: -0.1270 S33: -0.0404 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 184 A 275 REMARK 3 ORIGIN FOR THE GROUP (A): 12.7390 -2.5710 54.6550 REMARK 3 T TENSOR REMARK 3 T11: -0.0343 T22: -0.0549 REMARK 3 T33: -0.0753 T12: 0.0539 REMARK 3 T13: -0.0010 T23: 0.0045 REMARK 3 L TENSOR REMARK 3 L11: 1.4929 L22: 4.2927 REMARK 3 L33: 6.6683 L12: -0.2188 REMARK 3 L13: -0.4380 L23: -3.3102 REMARK 3 S TENSOR REMARK 3 S11: 0.1390 S12: -0.3246 S13: -0.2561 REMARK 3 S21: -0.2017 S22: -0.0885 S23: -0.0214 REMARK 3 S31: 0.2836 S32: 0.0492 S33: -0.0506 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 0 B 99 REMARK 3 ORIGIN FOR THE GROUP (A): -1.1260 5.5820 38.9880 REMARK 3 T TENSOR REMARK 3 T11: -0.0938 T22: 0.0564 REMARK 3 T33: -0.1652 T12: 0.0345 REMARK 3 T13: 0.0166 T23: 0.0583 REMARK 3 L TENSOR REMARK 3 L11: 2.6109 L22: 4.6592 REMARK 3 L33: 5.1070 L12: -1.0703 REMARK 3 L13: -1.1463 L23: 3.8883 REMARK 3 S TENSOR REMARK 3 S11: -0.1211 S12: -0.0611 S13: 0.0375 REMARK 3 S21: 0.2513 S22: -0.0597 S23: 0.4151 REMARK 3 S31: 0.1069 S32: -0.5382 S33: 0.1807 REMARK 3 REMARK 3 TLS GROUP : 4 REMARK 3 NUMBER OF COMPONENTS GROUP : 2 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : E 0 E 116 REMARK 3 RESIDUE RANGE : F 1 F 116 REMARK 3 ORIGIN FOR THE GROUP (A): 26.3540 0.4930 -7.4430 REMARK 3 T TENSOR REMARK 3 T11: -0.0783 T22: -0.1257 REMARK 3 T33: -0.1416 T12: -0.0138 REMARK 3 T13: 0.0388 T23: -0.0062 REMARK 3 L TENSOR REMARK 3 L11: 2.0403 L22: 0.8070 REMARK 3 L33: 1.5434 L12: -0.3851 REMARK 3 L13: -0.2263 L23: -0.3467 REMARK 3 S TENSOR REMARK 3 S11: -0.0013 S12: 0.0694 S13: -0.0210 REMARK 3 S21: -0.0037 S22: -0.0060 S23: 0.0720 REMARK 3 S31: -0.1483 S32: -0.0482 S33: 0.0072 REMARK 3 REMARK 3 TLS GROUP : 5 REMARK 3 NUMBER OF COMPONENTS GROUP : 2 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : E 117 E 198 REMARK 3 RESIDUE RANGE : F 117 F 245 REMARK 3 ORIGIN FOR THE GROUP (A): 33.7880 0.4300 -38.7730 REMARK 3 T TENSOR REMARK 3 T11: -0.0984 T22: 0.0615 REMARK 3 T33: -0.1056 T12: -0.0527 REMARK 3 T13: -0.0253 T23: 0.0509 REMARK 3 L TENSOR REMARK 3 L11: 3.8007 L22: 3.1871 REMARK 3 L33: 2.1797 L12: -1.6613 REMARK 3 L13: -0.3114 L23: 0.6813 REMARK 3 S TENSOR REMARK 3 S11: 0.1063 S12: 0.3103 S13: 0.1742 REMARK 3 S21: -0.0986 S22: -0.1225 S23: -0.1178 REMARK 3 S31: -0.1781 S32: 0.1966 S33: 0.0161 REMARK 3 REMARK 3 TLS GROUP : 6 REMARK 3 NUMBER OF COMPONENTS GROUP : 2 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : H 1 H 183 REMARK 3 RESIDUE RANGE : J 1 J 9 REMARK 3 ORIGIN FOR THE GROUP (A): 16.1540 40.6940 24.5610 REMARK 3 T TENSOR REMARK 3 T11: -0.2079 T22: -0.1801 REMARK 3 T33: -0.2167 T12: -0.0195 REMARK 3 T13: 0.0567 T23: 0.0210 REMARK 3 L TENSOR REMARK 3 L11: 2.5951 L22: 2.9798 REMARK 3 L33: 2.8943 L12: 0.1418 REMARK 3 L13: -0.1423 L23: 0.6100 REMARK 3 S TENSOR REMARK 3 S11: -0.0065 S12: -0.0563 S13: -0.0245 REMARK 3 S21: -0.0298 S22: -0.0140 S23: 0.0185 REMARK 3 S31: 0.2233 S32: -0.2074 S33: 0.0205 REMARK 3 REMARK 3 TLS GROUP : 7 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : H 184 H 275 REMARK 3 ORIGIN FOR THE GROUP (A): 13.1980 39.6100 59.7180 REMARK 3 T TENSOR REMARK 3 T11: -0.0925 T22: -0.1004 REMARK 3 T33: -0.0644 T12: 0.0363 REMARK 3 T13: -0.0049 T23: -0.0471 REMARK 3 L TENSOR REMARK 3 L11: 2.0016 L22: 4.5406 REMARK 3 L33: 8.0216 L12: 0.3840 REMARK 3 L13: -0.6802 L23: -4.5091 REMARK 3 S TENSOR REMARK 3 S11: 0.0667 S12: -0.1579 S13: -0.2191 REMARK 3 S21: -0.0234 S22: 0.1116 S23: -0.0585 REMARK 3 S31: 0.3119 S32: -0.0077 S33: -0.1784 REMARK 3 REMARK 3 TLS GROUP : 8 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : I 0 I 99 REMARK 3 ORIGIN FOR THE GROUP (A): -0.8190 48.2330 44.0760 REMARK 3 T TENSOR REMARK 3 T11: -0.1775 T22: -0.0320 REMARK 3 T33: -0.1540 T12: 0.0026 REMARK 3 T13: 0.0206 T23: 0.0852 REMARK 3 L TENSOR REMARK 3 L11: 3.0614 L22: 4.5975 REMARK 3 L33: 5.5102 L12: -0.5609 REMARK 3 L13: -1.1222 L23: 3.3076 REMARK 3 S TENSOR REMARK 3 S11: -0.0866 S12: 0.0846 S13: 0.1191 REMARK 3 S21: 0.2053 S22: 0.0944 S23: 0.2543 REMARK 3 S31: 0.0751 S32: -0.3904 S33: -0.0078 REMARK 3 REMARK 3 TLS GROUP : 9 REMARK 3 NUMBER OF COMPONENTS GROUP : 2 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : L 0 L 116 REMARK 3 RESIDUE RANGE : M 1 M 116 REMARK 3 ORIGIN FOR THE GROUP (A): 26.6220 42.8960 -2.4930 REMARK 3 T TENSOR REMARK 3 T11: -0.1119 T22: -0.1377 REMARK 3 T33: -0.1376 T12: -0.0424 REMARK 3 T13: 0.0323 T23: -0.0193 REMARK 3 L TENSOR REMARK 3 L11: 1.8758 L22: 0.7828 REMARK 3 L33: 2.0600 L12: -0.5827 REMARK 3 L13: -0.1996 L23: -0.4709 REMARK 3 S TENSOR REMARK 3 S11: -0.0605 S12: 0.0611 S13: -0.0718 REMARK 3 S21: -0.0589 S22: 0.0489 S23: 0.0710 REMARK 3 S31: -0.1216 S32: -0.1352 S33: 0.0117 REMARK 3 REMARK 3 TLS GROUP : 10 REMARK 3 NUMBER OF COMPONENTS GROUP : 2 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : L 117 L 198 REMARK 3 RESIDUE RANGE : M 117 M 245 REMARK 3 ORIGIN FOR THE GROUP (A): 34.3170 43.6000 -33.6890 REMARK 3 T TENSOR REMARK 3 T11: -0.0084 T22: 0.0627 REMARK 3 T33: -0.0841 T12: -0.0349 REMARK 3 T13: -0.0428 T23: -0.0059 REMARK 3 L TENSOR REMARK 3 L11: 4.3365 L22: 2.9827 REMARK 3 L33: 2.2447 L12: -2.2185 REMARK 3 L13: -0.3155 L23: 0.1800 REMARK 3 S TENSOR REMARK 3 S11: 0.2294 S12: 0.2981 S13: 0.1034 REMARK 3 S21: -0.2303 S22: -0.1948 S23: -0.1018 REMARK 3 S31: -0.2838 S32: 0.2048 S33: -0.0345 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. RESIDUES 52-58 IN THE TCR CHAINS E AND L ARE REMARK 3 COMPLETELY DISORDERED AND THUS HAVE AN OCCUPANCY OF 0.0 REMARK 4 REMARK 4 2UWE COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 20-MAR-07. REMARK 100 THE DEPOSITION ID IS D_1290031981. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 03-MAR-05 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-BM REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 76682 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 83.9 REMARK 200 DATA REDUNDANCY : 2.760 REMARK 200 R MERGE (I) : 0.06000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.37 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.49 REMARK 200 COMPLETENESS FOR SHELL (%) : 67.2 REMARK 200 DATA REDUNDANCY IN SHELL : 2.20 REMARK 200 R MERGE FOR SHELL (I) : 0.35000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.640 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: REFMAC REMARK 200 STARTING MODEL: PDB ENTRY 1LP9 REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.55 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 14% PEG 8000, 1 M NACL, 25 MM HEPES, REMARK 280 PH 7.8 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 42.08900 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: PENTAMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 TOTAL BURIED SURFACE AREA: 12440 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 46230 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -77.5 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: PENTAMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 TOTAL BURIED SURFACE AREA: 12390 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 46140 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -79.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: H, I, J, L, M REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 ENGINEERED RESIDUE IN CHAIN A, THR 187 TO ALA REMARK 400 ENGINEERED RESIDUE IN CHAIN H, THR 187 TO ALA REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET F 0 REMARK 465 MET M 0 REMARK 475 REMARK 475 ZERO OCCUPANCY RESIDUES REMARK 475 THE FOLLOWING RESIDUES WERE MODELED WITH ZERO OCCUPANCY. REMARK 475 THE LOCATION AND PROPERTIES OF THESE RESIDUES MAY NOT REMARK 475 BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 475 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE) REMARK 475 M RES C SSEQI REMARK 475 ASP E 52 REMARK 475 ASN E 53 REMARK 475 LYS E 54 REMARK 475 ARG E 55 REMARK 475 PRO E 56 REMARK 475 GLU E 57 REMARK 475 HIS E 58 REMARK 475 ASP L 52 REMARK 475 ASN L 53 REMARK 475 LYS L 54 REMARK 475 ARG L 55 REMARK 475 PRO L 56 REMARK 475 GLU L 57 REMARK 475 HIS L 58 REMARK 475 GLN L 59 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 GLU A 19 CD OE1 OE2 REMARK 480 GLU A 173 CG CD OE1 OE2 REMARK 480 GLU A 177 CG CD OE1 OE2 REMARK 480 GLN A 226 CB CG CD OE1 NE2 REMARK 480 ASP A 227 CG OD1 OD2 REMARK 480 GLU B 77 CD OE1 OE2 REMARK 480 ASP E 137 CG OD1 OD2 REMARK 480 ASP E 174 CG OD1 OD2 REMARK 480 PHE E 189 CB CG CD1 CD2 CE1 CE2 CZ REMARK 480 GLU F 1 CD OE1 OE2 REMARK 480 LYS F 126 CE NZ REMARK 480 GLU F 222 CB CG CD OE1 OE2 REMARK 480 ARG F 244 CZ NH1 NH2 REMARK 480 GLU H 19 CD OE1 OE2 REMARK 480 GLU H 173 CD OE1 OE2 REMARK 480 GLU I 77 CD OE1 OE2 REMARK 480 GLN L 127 CD OE1 NE2 REMARK 480 PHE L 189 CB CG CD1 CD2 CE1 CE2 CZ REMARK 480 GLU L 197 CD OE1 OE2 REMARK 480 GLU M 158 CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 CB THR E 51 N ASP E 52 0.92 REMARK 500 OG1 THR E 51 N ASP E 52 0.99 REMARK 500 CE2 PHE L 189 CD1 ILE L 194 1.26 REMARK 500 CG2 THR L 51 N ASP L 52 1.33 REMARK 500 CG2 THR E 51 N ASP E 52 1.60 REMARK 500 OG1 THR E 51 CA ASP E 52 1.77 REMARK 500 CZ PHE L 189 CD1 ILE L 194 2.00 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 CE MET E 173 OD1 ASN L 185 1545 2.04 REMARK 500 NH2 ARG A 169 OE2 GLU L 197 2645 2.11 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLN A 226 CA GLN A 226 CB -0.426 REMARK 500 ASP A 227 CB ASP A 227 CG -0.198 REMARK 500 HIS E 58 C GLN E 59 N 0.146 REMARK 500 ASP E 174 CB ASP E 174 CG -0.244 REMARK 500 GLU F 1 CG GLU F 1 CD -0.299 REMARK 500 LYS F 126 CD LYS F 126 CE 0.320 REMARK 500 ARG F 244 NE ARG F 244 CZ 0.131 REMARK 500 GLU H 19 CG GLU H 19 CD -0.122 REMARK 500 PRO L 56 N PRO L 56 CA -0.106 REMARK 500 GLN L 59 C GLY L 61 N -0.178 REMARK 500 PHE L 189 CA PHE L 189 CB 0.328 REMARK 500 GLU M 158 CG GLU M 158 CD 0.178 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 GLU A 19 CB - CG - CD ANGL. DEV. = 16.6 DEGREES REMARK 500 GLU A 19 CG - CD - OE1 ANGL. DEV. = -15.7 DEGREES REMARK 500 GLU A 19 CG - CD - OE2 ANGL. DEV. = 15.6 DEGREES REMARK 500 ASP A 227 CA - CB - CG ANGL. DEV. = 19.1 DEGREES REMARK 500 ASP A 227 CB - CG - OD1 ANGL. DEV. = -5.8 DEGREES REMARK 500 ASP E 52 N - CA - CB ANGL. DEV. = 22.2 DEGREES REMARK 500 PRO E 56 C - N - CA ANGL. DEV. = 10.4 DEGREES REMARK 500 HIS E 58 O - C - N ANGL. DEV. = -13.8 DEGREES REMARK 500 THR E 198 CA - C - O ANGL. DEV. = 41.8 DEGREES REMARK 500 GLU F 1 CB - CG - CD ANGL. DEV. = -18.7 DEGREES REMARK 500 ARG F 244 NE - CZ - NH1 ANGL. DEV. = -10.4 DEGREES REMARK 500 ARG F 244 NE - CZ - NH2 ANGL. DEV. = 5.7 DEGREES REMARK 500 GLU H 19 CG - CD - OE1 ANGL. DEV. = 12.9 DEGREES REMARK 500 GLU H 19 CG - CD - OE2 ANGL. DEV. = -12.7 DEGREES REMARK 500 PRO L 56 C - N - CA ANGL. DEV. = 18.4 DEGREES REMARK 500 PRO L 56 CA - N - CD ANGL. DEV. = -15.3 DEGREES REMARK 500 PRO L 56 CB - CA - C ANGL. DEV. = -16.5 DEGREES REMARK 500 GLU L 57 CA - C - N ANGL. DEV. = 19.7 DEGREES REMARK 500 GLU L 57 O - C - N ANGL. DEV. = -12.0 DEGREES REMARK 500 HIS L 58 CA - CB - CG ANGL. DEV. = -11.5 DEGREES REMARK 500 HIS L 58 N - CA - C ANGL. DEV. = 18.4 DEGREES REMARK 500 GLN L 59 C - N - CA ANGL. DEV. = 21.5 DEGREES REMARK 500 GLY L 61 C - N - CA ANGL. DEV. = -19.9 DEGREES REMARK 500 GLN L 127 CG - CD - NE2 ANGL. DEV. = 15.5 DEGREES REMARK 500 PHE L 189 N - CA - CB ANGL. DEV. = -12.2 DEGREES REMARK 500 GLU M 158 CG - CD - OE1 ANGL. DEV. = -13.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 29 -115.02 50.41 REMARK 500 HIS A 114 107.10 -162.21 REMARK 500 TYR A 123 -67.50 -106.09 REMARK 500 ASP A 137 -169.57 -128.55 REMARK 500 ASP A 227 22.43 -140.55 REMARK 500 ASN E 53 5.77 -62.52 REMARK 500 LYS E 54 -44.76 138.29 REMARK 500 ARG E 55 -125.74 -65.21 REMARK 500 GLU E 57 -127.46 -153.00 REMARK 500 HIS E 58 -144.23 -5.81 REMARK 500 PHE E 73 58.76 -146.14 REMARK 500 ALA E 97 15.26 -150.43 REMARK 500 MET E 173 117.49 -35.34 REMARK 500 ASP E 174 82.41 40.08 REMARK 500 ILE F 46 -62.14 -93.19 REMARK 500 PRO F 154 -166.27 -69.44 REMARK 500 ASP H 29 -113.29 54.92 REMARK 500 HIS H 114 106.53 -167.71 REMARK 500 TYR H 123 -68.67 -108.76 REMARK 500 TRP I 60 0.67 80.40 REMARK 500 LYS L 54 -66.30 139.59 REMARK 500 ARG L 55 -168.96 -53.71 REMARK 500 PRO L 56 -94.83 -130.41 REMARK 500 GLU L 57 -10.39 138.17 REMARK 500 HIS L 58 -119.31 -120.61 REMARK 500 PHE L 73 61.57 -150.72 REMARK 500 ALA L 97 7.55 -150.52 REMARK 500 MET L 173 48.45 -144.02 REMARK 500 ILE M 46 -61.21 -91.86 REMARK 500 PRO M 154 -161.56 -78.67 REMARK 500 ASP M 155 42.12 -99.62 REMARK 500 SER M 182 -166.29 -129.22 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ARG E 55 PRO E 56 -139.36 REMARK 500 PRO E 56 GLU E 57 148.46 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 ASP E 137 0.07 SIDE CHAIN REMARK 500 ARG F 244 0.12 SIDE CHAIN REMARK 500 GLU M 158 0.11 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 HIS E 58 -13.85 REMARK 500 GLN L 59 -10.00 REMARK 500 REMARK 500 REMARK: NULL REMARK 700 REMARK 700 SHEET REMARK 700 THE SHEET STRUCTURE OF THIS MOLECULE IS BIFURCATED. IN REMARK 700 ORDER TO REPRESENT THIS FEATURE IN THE SHEET RECORDS BELOW, REMARK 700 TWO SHEETS ARE DEFINED. REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1AKJ RELATED DB: PDB REMARK 900 COMPLEX OF THE HUMAN MHC CLASS I GLYCOPROTEIN HLA-A2 ANDTHE T CELL REMARK 900 CORECEPTOR CD8 REMARK 900 RELATED ID: 1AO7 RELATED DB: PDB REMARK 900 COMPLEX BETWEEN HUMAN T-CELL RECEPTOR, VIRAL PEPTIDE (TAX), AND HLA- REMARK 900 A 0201 REMARK 900 RELATED ID: 1AQD RELATED DB: PDB REMARK 900 HLA-DR1 (DRA, DRB1 0101) HUMAN CLASS II HISTOCOMPATIBILITYPROTEIN REMARK 900 (EXTRACELLULAR DOMAIN) COMPLEXED WITH ENDOGENOUSPEPTIDE REMARK 900 RELATED ID: 1B0G RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CLASS I MHC ( HLA-A2.1) COMPLEXED WITH REMARK 900 BETA 2- MICROGLOBULIN AND HUMAN PEPTIDE P1049 REMARK 900 RELATED ID: 1B0R RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-A0201 COMPLEXED WITH A PEPTIDE WITH THE REMARK 900 CARBOXYL-TERMINAL GROUP SUBSTITUTED BY A METHYL GROUP REMARK 900 RELATED ID: 1BD2 RELATED DB: PDB REMARK 900 COMPLEX BETWEEN HUMAN T-CELL RECEPTOR B7, VIRAL PEPTIDE (TAX) AND REMARK 900 MHC CLASS I MOLECULE HLA-A 0201 REMARK 900 RELATED ID: 1DUY RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-A0201/OCTAMERIC TAX PEPTIDE COMPLEX REMARK 900 RELATED ID: 1DUZ RELATED DB: PDB REMARK 900 HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA -A 0201) INCOMPLEX REMARK 900 WITH A NONAMERIC PEPTIDE FROM HTLV-1 TAX PROTEIN REMARK 900 RELATED ID: 1EEY RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE DETERMINATION OF HLA A2 COMPLEXED TOPEPTIDE GP2 REMARK 900 WITH THE SUBSTITUTION (I2L/V5L/L9V) REMARK 900 RELATED ID: 1EEZ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE DETERMINATION OF HLA-A2.1 COMPLEXED TOGP2 PEPTIDE REMARK 900 VARIANT(I2L/V5L) REMARK 900 RELATED ID: 1HHG RELATED DB: PDB REMARK 900 RELATED ID: 1HHH RELATED DB: PDB REMARK 900 RELATED ID: 1HHI RELATED DB: PDB REMARK 900 RELATED ID: 1HHJ RELATED DB: PDB REMARK 900 HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA -A 0201) COMPLEX WITH REMARK 900 A NONAMERIC PEPTIDE FROM HIV-1 REVERSE TRANSCRIPTASE (RESIDUES 309- REMARK 900 317) REMARK 900 RELATED ID: 1HHK RELATED DB: PDB REMARK 900 RELATED ID: 1HLA RELATED DB: PDB REMARK 900 HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN A2 ( HLA-A2, HUMAN REMARK 900 LEUCOCYTE ANTIGEN) REMARK 900 RELATED ID: 1I1F RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CLASS I MHC ( HLA-A2.1) COMPLEXED WITH REMARK 900 BETA 2- MICROGLOBULIN AND HIV-RT VARIANT PEPTIDE I1Y REMARK 900 RELATED ID: 1I1Y RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CLASS I MHC ( HLA-A2.1) COMPLEXED WITH REMARK 900 BETA 2- MICROGLOBULIN AND HIV-RT VARIANT PEPTIDE I1Y REMARK 900 RELATED ID: 1I4F RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-A*0201/MAGE-A4- PEPTIDE COMPLEX REMARK 900 RELATED ID: 1I7R RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDEP1058 REMARK 900 RELATED ID: 1I7T RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDEP1049-5V REMARK 900 RELATED ID: 1I7U RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDEP1049-6V REMARK 900 RELATED ID: 1IM3 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN CYTOMEGALOVIRUS PROTEIN US2BOUND TO REMARK 900 THE MHC CLASS I MOLECULE HLA-A2/TAX REMARK 900 RELATED ID: 1JF1 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-A2*0201 IN COMPLEX WITH ADECAMERIC ALTERED REMARK 900 PEPTIDE LIGAND FROM THE MART-1/MELAN-A REMARK 900 RELATED ID: 1JHT RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-A2*0201 IN COMPLEX WITH ANONAMERIC ALTERED REMARK 900 PEPTIDE LIGAND (ALGIGILTV) FROM THE MART-1/MELAN-A. REMARK 900 RELATED ID: 1LP9 RELATED DB: PDB REMARK 900 XENOREACTIVE COMPLEX AHIII 12.2 TCR BOUND TO P1049/HLA-A2.1 REMARK 900 RELATED ID: 1OGA RELATED DB: PDB REMARK 900 A STRUCTURAL BASIS FOR IMMUNODOMINANT HUMAN T-CELL RECEPTOR REMARK 900 RECOGNITION. REMARK 900 RELATED ID: 1P7Q RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-A2 BOUND TO LIR- 1, A HOST ANDVIRAL MHC REMARK 900 RECEPTOR REMARK 900 RELATED ID: 1QEW RELATED DB: PDB REMARK 900 HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA -A 0201)COMPLEX WITH REMARK 900 A NONAMERIC PEPTIDE FROM MELANOMA-ASSOCIATEDANTIGEN 3 (RESIDUES 271- REMARK 900 279) REMARK 900 RELATED ID: 1QR1 RELATED DB: PDB REMARK 900 POOR BINDING OF A HER-2/NEU EPITOPE (GP2 ) TO HLA-A2.1 IS DUE TO A REMARK 900 LACK OF INTERACTIONS IN THE CENTER OF THE PEPTIDE REMARK 900 RELATED ID: 1QRN RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN A6 TCR COMPLEXED WITH HLA-A2 BOUND TO REMARK 900 ALTERED HTLV-1 TAX PEPTIDE P6A REMARK 900 RELATED ID: 1QSE RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN A6-TCR BOUND TO HLA- A2 COMPLEXED WITH ALTERED REMARK 900 HTLV-1 TAX PEPTIDE V7R REMARK 900 RELATED ID: 1QSF RELATED DB: PDB REMARK 900 STRUCTURE OF A6-TCR BOUND TO HLA-A2 COMPLEXED WITH ALTERED HTLV-1 REMARK 900 TAX PEPTIDE Y8A REMARK 900 RELATED ID: 1S8D RELATED DB: PDB REMARK 900 STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDEVARIANTS REMARK 900 BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9-3A REMARK 900 RELATED ID: 1S9W RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE ANALYSIS OF NY-ESO-1 EPITOPE, SLLMWITQC,IN REMARK 900 COMPLEX WITH HLA-A2 REMARK 900 RELATED ID: 1S9X RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE ANALYSIS OF NY-ESO-1 EPITOPE ANALOGUE,SLLMWITQA, REMARK 900 IN COMPLEX WITH HLA-A2 REMARK 900 RELATED ID: 1S9Y RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE ANALYSIS OF NY-ESO-1 EPITOPE ANALOGUE,SLLMWITQS, REMARK 900 IN COMPLEX WITH HLA-A2 REMARK 900 RELATED ID: 1T1W RELATED DB: PDB REMARK 900 STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDEVARIANTS REMARK 900 BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9-3F6I8V REMARK 900 RELATED ID: 1T1X RELATED DB: PDB REMARK 900 STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDEVARIANTS REMARK 900 BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9-4L REMARK 900 RELATED ID: 1T1Y RELATED DB: PDB REMARK 900 STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDEVARIANTS REMARK 900 BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9-5V REMARK 900 RELATED ID: 1T1Z RELATED DB: PDB REMARK 900 STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDEVARIANTS REMARK 900 BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9-6A REMARK 900 RELATED ID: 1T20 RELATED DB: PDB REMARK 900 STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDEVARIANTS REMARK 900 BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9-6I REMARK 900 RELATED ID: 1T21 RELATED DB: PDB REMARK 900 STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDEVARIANTS REMARK 900 BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9, MONOCLINICCRYSTAL REMARK 900 RELATED ID: 1T22 RELATED DB: PDB REMARK 900 STRUCTURAL BASIS FOR DEGENERATE RECOGNITION OF HIV PEPTIDEVARIANTS REMARK 900 BY CYTOTOXIC LYMPHOCYTE, VARIANT SL9,ORTHORHOMBIC CRYSTAL REMARK 900 RELATED ID: 1TVB RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MELANOMA ANTIGEN GP100( 209-217) BOUNDTO HUMAN REMARK 900 CLASS I MHC HLA- A2 REMARK 900 RELATED ID: 1TVH RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MODIFIED MELANOMA ANTIGEN GP100(209-T2M) BOUND REMARK 900 TO HUMAN CLASS I MHC HLA-A2 REMARK 900 RELATED ID: 1UR7 RELATED DB: PDB REMARK 900 MOLECULAR REFINEMENT OF ANTI-HLA-A2 USING LIGHT CHAIN SHUFFLING: A REMARK 900 STRUCTURAL MODEL FOR HLA ANTIBODY BINDING REMARK 900 RELATED ID: 2AV1 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HTLV-1 TAX PEPTIDE BOUND TO HUMANCLASS I MHC REMARK 900 HLA-A2 WITH THE E63Q AND K66A MUTATIONS IN THEHEAVY CHAIN. REMARK 900 RELATED ID: 2AV7 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HTLV-1 TAX PEPTIDE BOUND TO HUMANCLASS I MHC REMARK 900 HLA-A2 WITH THE K66A MUTATION IN THE HEAVYCHAIN. REMARK 900 RELATED ID: 2BNQ RELATED DB: PDB REMARK 900 STRUCTURAL AND KINETIC BASIS FOR HIGHTENED IMMUNOGENICITY OF T CELL REMARK 900 VACCINES REMARK 900 RELATED ID: 2BNR RELATED DB: PDB REMARK 900 STRUCTURAL AND KINETIC BASIS FOR HIGHTENED IMMUNOGENICITY OF T CELL REMARK 900 VACCINES REMARK 900 RELATED ID: 2BSU RELATED DB: PDB REMARK 900 T CELL CROSS-REACTIVITY AND CONFORMATIONAL CHANGES DURING TCR REMARK 900 ENGAGEMENT REMARK 900 RELATED ID: 2BSV RELATED DB: PDB REMARK 900 T CELL CROSS-REACTIVITY AND CONFORMATIONAL CHANGES DURING TCR REMARK 900 ENGAGEMENT REMARK 900 RELATED ID: 2C7U RELATED DB: PDB REMARK 900 CONFLICTING SELECTIVE FORCES AFFECT CD8 T- CELL RECEPTOR CONTACT REMARK 900 SITES IN AN HLA-A2 IMMUNODOMINANT HIV EPITOPE. REMARK 900 RELATED ID: 2CLR RELATED DB: PDB REMARK 900 HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA -A 0201) COMPLEXED REMARK 900 WITH A DECAMERIC PEPTIDE FROM CALRETICULIN REMARK 900 RELATED ID: 2GJ6 RELATED DB: PDB REMARK 900 THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2WITH THE REMARK 900 MODIFIED HTLV-1 TAX (Y5K-4-[3-INDOLYL]-BUTYRICACID) PEPTIDE REMARK 900 RELATED ID: 2JCC RELATED DB: PDB REMARK 900 AH3 RECOGNITION OF MUTANT HLA-A2 W167A REMARK 900 RELATED ID: 3HLA RELATED DB: PDB REMARK 900 HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN A2. 1 (HLA-A2.1 HUMAN REMARK 900 LEUCOCYTE ANTIGEN) REMARK 900 RELATED ID: 1A1M RELATED DB: PDB REMARK 900 MHC CLASS I MOLECULE B*5301 COMPLEXED WITH PEPTIDETYPDINQML FROM REMARK 900 GAG PROTEIN OF HIV2 REMARK 900 RELATED ID: 1A1N RELATED DB: PDB REMARK 900 MHC CLASS I MOLECULE B*3501 COMPLEXED WITH PEPTIDE VPLRPMTYFROM THE REMARK 900 NEF PROTEIN (75- 82) OF HIV1 REMARK 900 RELATED ID: 1A1O RELATED DB: PDB REMARK 900 MHC CLASS I MOLECULE B5301 COMPLEXED WITH PEPTIDE LS6 (KPIVQYDNF) REMARK 900 FROM THE MALARIA PARASITE P. FALCIPARUM REMARK 900 RELATED ID: 1A6Z RELATED DB: PDB REMARK 900 HFE (HUMAN) HEMOCHROMATOSIS PROTEIN REMARK 900 RELATED ID: 1A9B RELATED DB: PDB REMARK 900 DECAMER-LIKE CONFORMATION OF A NANO-PEPTIDE BOUND TO HLA-B 3501 DUE REMARK 900 TO NONSTANDARD POSITIONING OF THE C-TERMINUS REMARK 900 RELATED ID: 1A9E RELATED DB: PDB REMARK 900 DECAMER-LIKE CONFORMATION OF A NANO-PEPTIDE BOUND TO HLA-B 3501 DUE REMARK 900 TO NONSTANDARD POSITIONING OF THE C-TERMINUS REMARK 900 RELATED ID: 1AGB RELATED DB: PDB REMARK 900 ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8 - REMARK 900 HIV-1 GAG PEPTIDE (GGRKKYKL - 3R MUTATION) REMARK 900 RELATED ID: 1AGC RELATED DB: PDB REMARK 900 ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8 - REMARK 900 HIV-1 GAG PEPTIDE (GGKKKYQL - 7Q MUTATION) REMARK 900 RELATED ID: 1AGD RELATED DB: PDB REMARK 900 ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8 - REMARK 900 HIV-1 GAG PEPTIDE (GGKKKYKL - INDEX PEPTIDE) REMARK 900 RELATED ID: 1AGE RELATED DB: PDB REMARK 900 ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8 - REMARK 900 HIV-1 GAG PEPTIDE (GGKKKYRL - 7R MUTATION) REMARK 900 RELATED ID: 1AGF RELATED DB: PDB REMARK 900 ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8 - REMARK 900 HIV-1 GAG PEPTIDE (GGKKRYKL - 5R MUTATION) REMARK 900 RELATED ID: 1C16 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE ANALYSIS OF THE GAMMA/ DELTA T CELL LIGAND T22 REMARK 900 RELATED ID: 1CE6 RELATED DB: PDB REMARK 900 MHC CLASS I H-2DB COMPLEXED WITH A SENDAI VIRUSNUCLEOPROTEIN PEPTIDE REMARK 900 RELATED ID: 1CG9 RELATED DB: PDB REMARK 900 COMPLEX RECOGNITION OF THE SUPERTYPIC BW6- DETERMINANT ONHLA-B AND- REMARK 900 C MOLECULES BY THE MONOCLONAL ANTIBODY SFR8-B6 REMARK 900 RELATED ID: 1DE4 RELATED DB: PDB REMARK 900 HEMOCHROMATOSIS PROTEIN HFE COMPLEXED WITH TRANSFERRINRECEPTOR REMARK 900 RELATED ID: 1E27 RELATED DB: PDB REMARK 900 NONSTANDARD PEPTIDE BINDING OF HLA-B*5101 COMPLEXED WITH HIV REMARK 900 IMMUNODOMINANT EPITOPE KM1 (LPPVVAKEI) REMARK 900 RELATED ID: 1E28 RELATED DB: PDB REMARK 900 NONSTANDARD PEPTIDE BINDING OF HLA-B*5101 COMPLEXED WITH HIV REMARK 900 IMMUNODOMINANT EPITOPE KM2 (TAFTIPSI) REMARK 900 RELATED ID: 1EFX RELATED DB: PDB REMARK 900 STRUCTURE OF A COMPLEX BETWEEN THE HUMAN NATURAL KILLER CELL REMARK 900 RECEPTOR KIR2DL2 AND A CLASS I MHC LIGAND HLA-CW3 REMARK 900 RELATED ID: 1EXU RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN MHC-RELATED FC RECEPTOR REMARK 900 RELATED ID: 1GZP RELATED DB: PDB REMARK 900 CD1B IN COMPLEX WITH GM2 GANGLIOSIDE REMARK 900 RELATED ID: 1GZQ RELATED DB: PDB REMARK 900 CD1B IN COMPLEX WITH PHOPHATIDYLINOSITOL REMARK 900 RELATED ID: 1HSA RELATED DB: PDB REMARK 900 HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN HLA- B(ASTERISK)2705 REMARK 900 RELATED ID: 1HSB RELATED DB: PDB REMARK 900 CLASS I HISTOCOMPATIBILITY ANTIGEN AW68.1 ( LEUCOCYTE ANTIGEN) REMARK 900 RELATED ID: 1IM9 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN NATURAL KILLER CELLINHIBITORY REMARK 900 RECEPTOR KIR2DL1 BOUND TO ITS MHC LIGAND HLA-CW4 REMARK 900 RELATED ID: 1JGD RELATED DB: PDB REMARK 900 HLA-B*2709 BOUND TO DECA-PEPTIDE S10R REMARK 900 RELATED ID: 1JGE RELATED DB: PDB REMARK 900 HLA-B*2705 BOUND TO NONA-PEPTIDE M9 REMARK 900 RELATED ID: 1JNJ RELATED DB: PDB REMARK 900 NMR SOLUTION STRUCTURE OF THE HUMAN BETA2- MICROGLOBULIN REMARK 900 RELATED ID: 1K5N RELATED DB: PDB REMARK 900 HLA-B*2709 BOUND TO NONA-PEPTIDE M9 REMARK 900 RELATED ID: 1KPR RELATED DB: PDB REMARK 900 THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEXMOLECULE REMARK 900 HLA-E REMARK 900 RELATED ID: 1KTL RELATED DB: PDB REMARK 900 THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEXMOLECULE REMARK 900 HLA-E REMARK 900 RELATED ID: 1LDS RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MONOMERIC HUMAN BETA-2 -MICROGLOBULIN REMARK 900 RELATED ID: 1M05 RELATED DB: PDB REMARK 900 HLA B8 IN COMPLEX WITH AN EPSTEIN BARR VIRUS DETERMINANT REMARK 900 RELATED ID: 1M6O RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA B*4402 IN COMPLEX WITH HLADPA*0201 PEPTIDE REMARK 900 RELATED ID: 1MHE RELATED DB: PDB REMARK 900 THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE REMARK 900 HLA-E REMARK 900 RELATED ID: 1MI5 RELATED DB: PDB REMARK 900 THE CRYSTAL STRUCTURE OF LC13 TCR IN COMPLEX WITH HLAB8-EBVPEPTIDE REMARK 900 COMPLEX REMARK 900 RELATED ID: 1N2R RELATED DB: PDB REMARK 900 A NATURAL SELECTED DIMORPHISM IN HLA B*44 ALTERS SELF,PEPTIDE REMARK 900 REPORTOIRE AND T CELL RECOGNITION. REMARK 900 RELATED ID: 1OF2 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE VASOACTIVE REMARK 900 INTESTINAL PEPTIDE TYPE 1 RECEPTOR (VPAC1) PEPTIDE (RESIDUES 400- REMARK 900 408) REMARK 900 RELATED ID: 1OGT RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE VASOACTIVE REMARK 900 INTESTINAL PEPTIDE TYPE 1 RECEPTOR (VPAC1) PEPTIDE (RESIDUES 400- REMARK 900 408) REMARK 900 RELATED ID: 1ONQ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CD1A IN COMPLEX WITH A SULFATIDE REMARK 900 RELATED ID: 1PY4 RELATED DB: PDB REMARK 900 BETA2 MICROGLOBULIN MUTANT H31Y DISPLAYS HINTS FOR AMYLOIDFORMATIONS REMARK 900 RELATED ID: 1Q94 RELATED DB: PDB REMARK 900 STRUCTURES OF HLA-A*1101 IN COMPLEX WITH IMMUNODOMINANTNONAMER AND REMARK 900 DECAMER HIV-1 EPITOPES CLEARLY REVEAL THEPRESENCE OF A MIDDLE REMARK 900 ANCHOR RESIDUE REMARK 900 RELATED ID: 1QLF RELATED DB: PDB REMARK 900 MHC CLASS I H-2DB COMPLEXED WITH GLYCOPEPTIDE K3G REMARK 900 RELATED ID: 1QQD RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-CW4, A LIGAND FOR THE KIR2D NATURAL KILLER REMARK 900 CELL INHIBITORY RECEPTOR REMARK 900 RELATED ID: 1QVO RELATED DB: PDB REMARK 900 STRUCTURES OF HLA-A*1101 IN COMPLEX WITH IMMUNODOMINANTNONAMER AND REMARK 900 DECAMER HIV-1 EPITOPES CLEARLY REVEAL THEPRESENCE OF A MIDDLE REMARK 900 ANCHOR RESIDUE REMARK 900 RELATED ID: 1R3H RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF T10 REMARK 900 RELATED ID: 1SYS RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA, B*4403, AND PEPTIDE EEPTVIKKY REMARK 900 RELATED ID: 1SYV RELATED DB: PDB REMARK 900 HLA-B*4405 COMPLEXED TO THE DOMINANT SELF LIGAND EEFGRAYGF REMARK 900 RELATED ID: 1TMC RELATED DB: PDB REMARK 900 TRUNCATED HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN HLA-AW68 REMARK 900 COMPLEXED WITH A DECAMERIC PEPTIDE (EVAPPEYHRK) REMARK 900 RELATED ID: 1UQS RELATED DB: PDB REMARK 900 THE CRYSTAL STRUCTURE OF HUMAN CD1B WITH A BOUND BACTERIAL REMARK 900 GLYCOLIPID REMARK 900 RELATED ID: 1UXS RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE LATENT MEMBRANE REMARK 900 PROTEIN 2 PEPTIDE (LMP2)OF EPSTEIN-BARR VIRUS REMARK 900 RELATED ID: 1UXW RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE LATENT MEMBRANE REMARK 900 PROTEIN 2 PEPTIDE (LMP2) OF EPSTEIN-BARR VIRUS REMARK 900 RELATED ID: 1VGK RELATED DB: PDB REMARK 900 THE CRYSTAL STRUCTURE OF CLASS I MAJOR HISTOCOMPATIBILITYCOMPLEX, H- REMARK 900 2KD AT 2.0 A RESOLUTION REMARK 900 RELATED ID: 1W0V RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE SELF-PEPTIDE TIS REMARK 900 FROM EGF- RESPONSE FACTOR 1 REMARK 900 RELATED ID: 1W0W RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE SELF-PEPTIDE TIS REMARK 900 FROM EGF- RESPONSE FACTOR 1 REMARK 900 RELATED ID: 1W72 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-A1:MAGE-A1 IN COMPLEX WITH FAB-HYB3 REMARK 900 RELATED ID: 1X7Q RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-A*1101 WITH SARS NUCLEOCAPSIDPEPTIDE REMARK 900 RELATED ID: 1XH3 RELATED DB: PDB REMARK 900 CONFORMATIONAL RESTRAINTS AND FLEXIBILITY OF 14-MERICPEPTIDES IN REMARK 900 COMPLEX WITH HLA-B* 3501 REMARK 900 RELATED ID: 1XR8 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES OF HLA-B*1501 IN COMPLEX WITH PEPTIDESFROM HUMAN REMARK 900 UBCH6 AND EPSTEIN-BARR VIRUS EBNA-3 REMARK 900 RELATED ID: 1XR9 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES OF HLA-B*1501 IN COMPLEX WITH PEPTIDESFROM HUMAN REMARK 900 UBCH6 AND EPSTEIN-BARR VIRUS EBNA-3 REMARK 900 RELATED ID: 1XZ0 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CD1A IN COMPLEX WITH A SYNTHETICMYCOBACTIN REMARK 900 LIPOPEPTIDE REMARK 900 RELATED ID: 1YDP RELATED DB: PDB REMARK 900 1.9A CRYSTAL STRUCTURE OF HLA-G REMARK 900 RELATED ID: 1YPZ RELATED DB: PDB REMARK 900 IMMUNE RECEPTOR REMARK 900 RELATED ID: 1ZS8 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE MURINE MHC CLASS IB MOLECULE M10.5 REMARK 900 RELATED ID: 1ZSD RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-B*3501 PRESENTING AN 11-MER EBVANTIGEN REMARK 900 EPLPQGQLTAY REMARK 900 RELATED ID: 1ZT4 RELATED DB: PDB REMARK 900 THE CRYSTAL STRUCTURE OF HUMAN CD1D WITH AND WITHOUT ALPHA- REMARK 900 GALACTOSYLCERAMIDE REMARK 900 RELATED ID: 2A83 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE GLUCAGONRECEPTOR REMARK 900 (GR) PEPTIDE (RESIDUES 412-420) REMARK 900 RELATED ID: 2AK4 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF SB27 TCR IN COMPLEX WITH HLA-B*3508-13MER REMARK 900 PEPTIDE REMARK 900 RELATED ID: 2AXF RELATED DB: PDB REMARK 900 THE IMMUNOGENICITY OF A VIRAL CYTOTOXIC T CELL EPITOPE ISCONTROLLED REMARK 900 BY ITS MHC-BOUND CONFORMATION REMARK 900 RELATED ID: 2AXG RELATED DB: PDB REMARK 900 THE IMMUNOGENICITY OF A VIRAL CYTOTOXIC T CELL EPITOPE ISCONTROLLED REMARK 900 BY ITS MHC-BOUND CONFORMATION REMARK 900 RELATED ID: 2BCK RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-A*2402 COMPLEXED WITH A TELOMERASEPEPTIDE REMARK 900 RELATED ID: 2BSR RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES AND KIR3DL1 RECOGNITION OF THREE IMMUNODOMINANT REMARK 900 VIRAL PEPTIDES COMPLEXED TO HLA-B2705 REMARK 900 RELATED ID: 2BSS RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES AND KIR3DL1 RECOGNITION OF THREE IMMUNODOMINANT REMARK 900 VIRAL PEPTIDES COMPLEXED TO HLA-B2705 REMARK 900 RELATED ID: 2BST RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES AND KIR3DL1 RECOGNITION OF THREE IMMUNODOMINANT REMARK 900 VIRAL PEPTIDES COMPLEXED TO HLA-B2705 REMARK 900 RELATED ID: 2BVQ RELATED DB: PDB REMARK 900 STRUCTURES OF THREE HIV-1 HLA-B5703- PEPTIDE COMPLEXES AND REMARK 900 IDENTIFICATION OF RELATED HLAS POTENTIALLY ASSOCIATED WITH LONG - REMARK 900 TERM NON-PROGRESSION REMARK 900 RELATED ID: 2CII RELATED DB: PDB REMARK 900 THE CRYSTAL STRUCTURE OF H-2DB COMPLEXED WITH A PARTIAL PEPTIDE REMARK 900 EPITOPE SUGGESTS AN MHC CLASS I ASSEMBLY-INTERMEDIATE REMARK 900 RELATED ID: 2CIK RELATED DB: PDB REMARK 900 INSIGHTS INTO CROSSREACTIVITY IN HUMAN ALLORECOGNITION: THE REMARK 900 STRUCTURE OF HLA-B35011 PRESENTING AN EPITOPE DERIVED FROM REMARK 900 CYTOCHROME P450. REMARK 900 RELATED ID: 2D31 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF DISULFIDE-LINKED HLA-G DIMER REMARK 900 RELATED ID: 2ESV RELATED DB: PDB REMARK 900 STRUCTURE OF THE HLA-E-VMAPRTLIL/KK50.4 TCR COMPLEX REMARK 900 RELATED ID: 2F74 RELATED DB: PDB REMARK 900 MURINE MHC CLASS I H-2DB IN COMPLEX WITH HUMAN B2-MICROGLOBULIN AND REMARK 900 LCMV-DERIVED IMMUNODMINANT PEPTIDE GP33 REMARK 900 RELATED ID: 2F8O RELATED DB: PDB REMARK 900 A NATIVE TO AMYLOIDOGENIC TRANSITION REGULATED BY ABACKBONE TRIGGER REMARK 900 RELATED ID: 2H26 RELATED DB: PDB REMARK 900 HUMAN CD1B IN COMPLEX WITH ENDOGENOUS PHOSPHATIDYLCHOLINEAND SPACER REMARK 900 RELATED ID: 2HJK RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-B5703 AND HIV-1 PEPTIDE REMARK 900 RELATED ID: 2HJL RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-B5703 AND HIV-1 PEPTIDE REMARK 900 RELATED ID: 2HLA RELATED DB: PDB REMARK 900 HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN AW 68.1 (HLA-AW 68.1, REMARK 900 HUMAN LEUCOCYTE ANTIGEN) REMARK 999 REMARK 999 SEQUENCE REMARK 999 MUTANT T163A REMARK 999 ADDITIONAL METHIONINE AT N-TERMINUS DUE TO EXPRESSION IN E. REMARK 999 COLI DBREF 2UWE A 1 275 UNP P01892 1A02_HUMAN 25 299 DBREF 2UWE B 0 0 PDB 2UWE 2UWE 0 0 DBREF 2UWE B 1 99 UNP P61769 B2MG_HUMAN 21 119 DBREF 2UWE C 1 9 UNP Q9NPA0 CO024_HUMAN 4 12 DBREF 2UWE E 0 198 PDB 2UWE 2UWE 0 198 DBREF 2UWE F 0 245 PDB 2UWE 2UWE 0 245 DBREF 2UWE H 1 275 UNP P01892 1A02_HUMAN 25 299 DBREF 2UWE I 0 0 PDB 2UWE 2UWE 0 0 DBREF 2UWE I 1 99 UNP P61769 B2MG_HUMAN 21 119 DBREF 2UWE J 1 9 UNP Q9NPA0 CO024_HUMAN 4 12 DBREF 2UWE L 0 198 PDB 2UWE 2UWE 0 198 DBREF 2UWE M 0 245 PDB 2UWE 2UWE 0 245 SEQADV 2UWE ALA A 163 UNP P01892 THR 187 ENGINEERED MUTATION SEQADV 2UWE ALA H 163 UNP P01892 THR 187 ENGINEERED MUTATION SEQRES 1 A 275 GLY SER HIS SER MET ARG TYR PHE PHE THR SER VAL SER SEQRES 2 A 275 ARG PRO GLY ARG GLY GLU PRO ARG PHE ILE ALA VAL GLY SEQRES 3 A 275 TYR VAL ASP ASP THR GLN PHE VAL ARG PHE ASP SER ASP SEQRES 4 A 275 ALA ALA SER GLN ARG MET GLU PRO ARG ALA PRO TRP ILE SEQRES 5 A 275 GLU GLN GLU GLY PRO GLU TYR TRP ASP GLY GLU THR ARG SEQRES 6 A 275 LYS VAL LYS ALA HIS SER GLN THR HIS ARG VAL ASP LEU SEQRES 7 A 275 GLY THR LEU ARG GLY TYR TYR ASN GLN SER GLU ALA GLY SEQRES 8 A 275 SER HIS THR VAL GLN ARG MET TYR GLY CYS ASP VAL GLY SEQRES 9 A 275 SER ASP TRP ARG PHE LEU ARG GLY TYR HIS GLN TYR ALA SEQRES 10 A 275 TYR ASP GLY LYS ASP TYR ILE ALA LEU LYS GLU ASP LEU SEQRES 11 A 275 ARG SER TRP THR ALA ALA ASP MET ALA ALA GLN THR THR SEQRES 12 A 275 LYS HIS LYS TRP GLU ALA ALA HIS VAL ALA GLU GLN LEU SEQRES 13 A 275 ARG ALA TYR LEU GLU GLY ALA CYS VAL GLU TRP LEU ARG SEQRES 14 A 275 ARG TYR LEU GLU ASN GLY LYS GLU THR LEU GLN ARG THR SEQRES 15 A 275 ASP ALA PRO LYS THR HIS MET THR HIS HIS ALA VAL SER SEQRES 16 A 275 ASP HIS GLU ALA THR LEU ARG CYS TRP ALA LEU SER PHE SEQRES 17 A 275 TYR PRO ALA GLU ILE THR LEU THR TRP GLN ARG ASP GLY SEQRES 18 A 275 GLU ASP GLN THR GLN ASP THR GLU LEU VAL GLU THR ARG SEQRES 19 A 275 PRO ALA GLY ASP GLY THR PHE GLN LYS TRP ALA ALA VAL SEQRES 20 A 275 VAL VAL PRO SER GLY GLN GLU GLN ARG TYR THR CYS HIS SEQRES 21 A 275 VAL GLN HIS GLU GLY LEU PRO LYS PRO LEU THR LEU ARG SEQRES 22 A 275 TRP GLU SEQRES 1 B 100 MET ILE GLN ARG THR PRO LYS ILE GLN VAL TYR SER ARG SEQRES 2 B 100 HIS PRO ALA GLU ASN GLY LYS SER ASN PHE LEU ASN CYS SEQRES 3 B 100 TYR VAL SER GLY PHE HIS PRO SER ASP ILE GLU VAL ASP SEQRES 4 B 100 LEU LEU LYS ASN GLY GLU ARG ILE GLU LYS VAL GLU HIS SEQRES 5 B 100 SER ASP LEU SER PHE SER LYS ASP TRP SER PHE TYR LEU SEQRES 6 B 100 LEU TYR TYR THR GLU PHE THR PRO THR GLU LYS ASP GLU SEQRES 7 B 100 TYR ALA CYS ARG VAL ASN HIS VAL THR LEU SER GLN PRO SEQRES 8 B 100 LYS ILE VAL LYS TRP ASP ARG ASP MET SEQRES 1 C 9 ALA LEU TRP GLY PHE PHE PRO VAL LEU SEQRES 1 E 194 MET ASP SER VAL THR GLN THR GLU GLY LEU VAL THR LEU SEQRES 2 E 194 THR GLU GLY LEU PRO VAL MET LEU ASN CYS THR TYR GLN SEQRES 3 E 194 SER THR TYR SER PRO PHE LEU PHE TRP TYR VAL GLN HIS SEQRES 4 E 194 LEU ASN GLU ALA PRO LYS LEU LEU LEU LYS SER PHE THR SEQRES 5 E 194 ASP ASN LYS ARG PRO GLU HIS GLN GLY PHE HIS ALA THR SEQRES 6 E 194 LEU HIS LYS SER SER SER SER PHE HIS LEU GLN LYS SER SEQRES 7 E 194 SER ALA GLN LEU SER ASP SER ALA LEU TYR TYR CYS ALA SEQRES 8 E 194 LEU PHE LEU ALA SER SER SER PHE SER LYS LEU VAL PHE SEQRES 9 E 194 GLY GLN GLY THR SER LEU SER VAL VAL PRO ASN ILE GLN SEQRES 10 E 194 ASN PRO GLU PRO ALA VAL TYR GLN LEU LYS ASP PRO ARG SEQRES 11 E 194 SER GLN ASP SER THR LEU CYS LEU PHE THR ASP PHE ASP SEQRES 12 E 194 SER GLN ILE ASN VAL PRO LYS THR MET GLU SER GLY THR SEQRES 13 E 194 PHE ILE THR ASP LYS THR VAL LEU ASP MET LYS ALA MET SEQRES 14 E 194 ASP SER LYS SER ASN GLY ALA ILE ALA TRP SER ASN GLN SEQRES 15 E 194 THR SER PHE THR CYS GLN ASP ILE PHE LYS GLU THR SEQRES 1 F 238 MET GLU ALA ALA VAL THR GLN SER PRO ARG SER LYS VAL SEQRES 2 F 238 ALA VAL THR GLY GLY LYS VAL THR LEU SER CYS HIS GLN SEQRES 3 F 238 THR ASN ASN HIS ASP TYR MET TYR TRP TYR ARG GLN ASP SEQRES 4 F 238 THR GLY HIS GLY LEU ARG LEU ILE HIS TYR SER TYR VAL SEQRES 5 F 238 ALA ASP SER THR GLU LYS GLY ASP ILE PRO ASP GLY TYR SEQRES 6 F 238 LYS ALA SER ARG PRO SER GLN GLU ASN PHE SER LEU ILE SEQRES 7 F 238 LEU GLU LEU ALA SER LEU SER GLN THR ALA VAL TYR PHE SEQRES 8 F 238 CYS ALA SER SER ASP TRP VAL SER TYR GLU GLN TYR PHE SEQRES 9 F 238 GLY PRO GLY THR ARG LEU THR VAL LEU GLU ASP LEU ARG SEQRES 10 F 238 ASN VAL THR PRO PRO LYS VAL SER LEU PHE GLU PRO SER SEQRES 11 F 238 LYS ALA GLU ILE ALA ASN LYS GLN LYS ALA THR LEU VAL SEQRES 12 F 238 CYS LEU ALA ARG GLY PHE PHE PRO ASP HIS VAL GLU LEU SEQRES 13 F 238 SER TRP TRP VAL ASN GLY LYS GLU VAL HIS SER GLY VAL SEQRES 14 F 238 SER THR ASP PRO GLN ALA TYR LYS GLU SER ASN TYR SER SEQRES 15 F 238 TYR ALA LEU SER SER ARG LEU ARG VAL SER ALA THR PHE SEQRES 16 F 238 TRP HIS ASN PRO ARG ASN HIS PHE ARG CYS GLN VAL GLN SEQRES 17 F 238 PHE HIS GLY LEU SER GLU GLU ASP LYS TRP PRO GLU GLY SEQRES 18 F 238 SER PRO LYS PRO VAL THR GLN ASN ILE SER ALA GLU ALA SEQRES 19 F 238 TRP GLY ARG ALA SEQRES 1 H 275 GLY SER HIS SER MET ARG TYR PHE PHE THR SER VAL SER SEQRES 2 H 275 ARG PRO GLY ARG GLY GLU PRO ARG PHE ILE ALA VAL GLY SEQRES 3 H 275 TYR VAL ASP ASP THR GLN PHE VAL ARG PHE ASP SER ASP SEQRES 4 H 275 ALA ALA SER GLN ARG MET GLU PRO ARG ALA PRO TRP ILE SEQRES 5 H 275 GLU GLN GLU GLY PRO GLU TYR TRP ASP GLY GLU THR ARG SEQRES 6 H 275 LYS VAL LYS ALA HIS SER GLN THR HIS ARG VAL ASP LEU SEQRES 7 H 275 GLY THR LEU ARG GLY TYR TYR ASN GLN SER GLU ALA GLY SEQRES 8 H 275 SER HIS THR VAL GLN ARG MET TYR GLY CYS ASP VAL GLY SEQRES 9 H 275 SER ASP TRP ARG PHE LEU ARG GLY TYR HIS GLN TYR ALA SEQRES 10 H 275 TYR ASP GLY LYS ASP TYR ILE ALA LEU LYS GLU ASP LEU SEQRES 11 H 275 ARG SER TRP THR ALA ALA ASP MET ALA ALA GLN THR THR SEQRES 12 H 275 LYS HIS LYS TRP GLU ALA ALA HIS VAL ALA GLU GLN LEU SEQRES 13 H 275 ARG ALA TYR LEU GLU GLY ALA CYS VAL GLU TRP LEU ARG SEQRES 14 H 275 ARG TYR LEU GLU ASN GLY LYS GLU THR LEU GLN ARG THR SEQRES 15 H 275 ASP ALA PRO LYS THR HIS MET THR HIS HIS ALA VAL SER SEQRES 16 H 275 ASP HIS GLU ALA THR LEU ARG CYS TRP ALA LEU SER PHE SEQRES 17 H 275 TYR PRO ALA GLU ILE THR LEU THR TRP GLN ARG ASP GLY SEQRES 18 H 275 GLU ASP GLN THR GLN ASP THR GLU LEU VAL GLU THR ARG SEQRES 19 H 275 PRO ALA GLY ASP GLY THR PHE GLN LYS TRP ALA ALA VAL SEQRES 20 H 275 VAL VAL PRO SER GLY GLN GLU GLN ARG TYR THR CYS HIS SEQRES 21 H 275 VAL GLN HIS GLU GLY LEU PRO LYS PRO LEU THR LEU ARG SEQRES 22 H 275 TRP GLU SEQRES 1 I 100 MET ILE GLN ARG THR PRO LYS ILE GLN VAL TYR SER ARG SEQRES 2 I 100 HIS PRO ALA GLU ASN GLY LYS SER ASN PHE LEU ASN CYS SEQRES 3 I 100 TYR VAL SER GLY PHE HIS PRO SER ASP ILE GLU VAL ASP SEQRES 4 I 100 LEU LEU LYS ASN GLY GLU ARG ILE GLU LYS VAL GLU HIS SEQRES 5 I 100 SER ASP LEU SER PHE SER LYS ASP TRP SER PHE TYR LEU SEQRES 6 I 100 LEU TYR TYR THR GLU PHE THR PRO THR GLU LYS ASP GLU SEQRES 7 I 100 TYR ALA CYS ARG VAL ASN HIS VAL THR LEU SER GLN PRO SEQRES 8 I 100 LYS ILE VAL LYS TRP ASP ARG ASP MET SEQRES 1 J 9 ALA LEU TRP GLY PHE PHE PRO VAL LEU SEQRES 1 L 194 MET ASP SER VAL THR GLN THR GLU GLY LEU VAL THR LEU SEQRES 2 L 194 THR GLU GLY LEU PRO VAL MET LEU ASN CYS THR TYR GLN SEQRES 3 L 194 SER THR TYR SER PRO PHE LEU PHE TRP TYR VAL GLN HIS SEQRES 4 L 194 LEU ASN GLU ALA PRO LYS LEU LEU LEU LYS SER PHE THR SEQRES 5 L 194 ASP ASN LYS ARG PRO GLU HIS GLN GLY PHE HIS ALA THR SEQRES 6 L 194 LEU HIS LYS SER SER SER SER PHE HIS LEU GLN LYS SER SEQRES 7 L 194 SER ALA GLN LEU SER ASP SER ALA LEU TYR TYR CYS ALA SEQRES 8 L 194 LEU PHE LEU ALA SER SER SER PHE SER LYS LEU VAL PHE SEQRES 9 L 194 GLY GLN GLY THR SER LEU SER VAL VAL PRO ASN ILE GLN SEQRES 10 L 194 ASN PRO GLU PRO ALA VAL TYR GLN LEU LYS ASP PRO ARG SEQRES 11 L 194 SER GLN ASP SER THR LEU CYS LEU PHE THR ASP PHE ASP SEQRES 12 L 194 SER GLN ILE ASN VAL PRO LYS THR MET GLU SER GLY THR SEQRES 13 L 194 PHE ILE THR ASP LYS THR VAL LEU ASP MET LYS ALA MET SEQRES 14 L 194 ASP SER LYS SER ASN GLY ALA ILE ALA TRP SER ASN GLN SEQRES 15 L 194 THR SER PHE THR CYS GLN ASP ILE PHE LYS GLU THR SEQRES 1 M 238 MET GLU ALA ALA VAL THR GLN SER PRO ARG SER LYS VAL SEQRES 2 M 238 ALA VAL THR GLY GLY LYS VAL THR LEU SER CYS HIS GLN SEQRES 3 M 238 THR ASN ASN HIS ASP TYR MET TYR TRP TYR ARG GLN ASP SEQRES 4 M 238 THR GLY HIS GLY LEU ARG LEU ILE HIS TYR SER TYR VAL SEQRES 5 M 238 ALA ASP SER THR GLU LYS GLY ASP ILE PRO ASP GLY TYR SEQRES 6 M 238 LYS ALA SER ARG PRO SER GLN GLU ASN PHE SER LEU ILE SEQRES 7 M 238 LEU GLU LEU ALA SER LEU SER GLN THR ALA VAL TYR PHE SEQRES 8 M 238 CYS ALA SER SER ASP TRP VAL SER TYR GLU GLN TYR PHE SEQRES 9 M 238 GLY PRO GLY THR ARG LEU THR VAL LEU GLU ASP LEU ARG SEQRES 10 M 238 ASN VAL THR PRO PRO LYS VAL SER LEU PHE GLU PRO SER SEQRES 11 M 238 LYS ALA GLU ILE ALA ASN LYS GLN LYS ALA THR LEU VAL SEQRES 12 M 238 CYS LEU ALA ARG GLY PHE PHE PRO ASP HIS VAL GLU LEU SEQRES 13 M 238 SER TRP TRP VAL ASN GLY LYS GLU VAL HIS SER GLY VAL SEQRES 14 M 238 SER THR ASP PRO GLN ALA TYR LYS GLU SER ASN TYR SER SEQRES 15 M 238 TYR ALA LEU SER SER ARG LEU ARG VAL SER ALA THR PHE SEQRES 16 M 238 TRP HIS ASN PRO ARG ASN HIS PHE ARG CYS GLN VAL GLN SEQRES 17 M 238 PHE HIS GLY LEU SER GLU GLU ASP LYS TRP PRO GLU GLY SEQRES 18 M 238 SER PRO LYS PRO VAL THR GLN ASN ILE SER ALA GLU ALA SEQRES 19 M 238 TRP GLY ARG ALA FORMUL 11 HOH *210(H2 O) HELIX 1 1 PRO A 50 GLU A 55 5 6 HELIX 2 2 GLY A 56 TYR A 85 1 30 HELIX 3 3 ASP A 137 ALA A 150 1 14 HELIX 4 4 HIS A 151 GLY A 162 1 12 HELIX 5 5 GLY A 162 GLY A 175 1 14 HELIX 6 6 GLY A 175 GLN A 180 1 6 HELIX 7 7 GLN A 253 GLN A 255 5 3 HELIX 8 8 GLN E 81 SER E 85 5 5 HELIX 9 9 SER F 83 THR F 87 5 5 HELIX 10 10 ASP F 118 VAL F 122 5 5 HELIX 11 11 SER F 133 GLN F 141 1 9 HELIX 12 12 ALA F 200 ASN F 205 1 6 HELIX 13 13 GLY H 56 TYR H 85 1 30 HELIX 14 14 ASP H 137 ALA H 150 1 14 HELIX 15 15 HIS H 151 GLY H 162 1 12 HELIX 16 16 GLY H 162 GLY H 175 1 14 HELIX 17 17 GLY H 175 GLN H 180 1 6 HELIX 18 18 GLN H 253 GLN H 255 5 3 HELIX 19 19 GLN L 81 SER L 85 5 5 HELIX 20 20 SER M 83 THR M 87 5 5 HELIX 21 21 ASP M 118 VAL M 122 5 5 HELIX 22 22 SER M 133 GLN M 141 1 9 HELIX 23 23 ALA M 200 ASN M 205 1 6 SHEET 1 AA 8 GLU A 46 PRO A 47 0 SHEET 2 AA 8 THR A 31 ASP A 37 -1 O ARG A 35 N GLU A 46 SHEET 3 AA 8 ARG A 21 VAL A 28 -1 O ALA A 24 N PHE A 36 SHEET 4 AA 8 HIS A 3 VAL A 12 -1 O ARG A 6 N TYR A 27 SHEET 5 AA 8 THR A 94 VAL A 103 -1 O VAL A 95 N SER A 11 SHEET 6 AA 8 PHE A 109 TYR A 118 -1 N LEU A 110 O ASP A 102 SHEET 7 AA 8 LYS A 121 LEU A 126 -1 O LYS A 121 N TYR A 118 SHEET 8 AA 8 TRP A 133 ALA A 135 -1 O THR A 134 N ALA A 125 SHEET 1 AB 4 LYS A 186 ALA A 193 0 SHEET 2 AB 4 GLU A 198 PHE A 208 -1 O THR A 200 N HIS A 192 SHEET 3 AB 4 PHE A 241 PRO A 250 -1 O PHE A 241 N PHE A 208 SHEET 4 AB 4 THR A 228 LEU A 230 -1 O GLU A 229 N ALA A 246 SHEET 1 AC 4 LYS A 186 ALA A 193 0 SHEET 2 AC 4 GLU A 198 PHE A 208 -1 O THR A 200 N HIS A 192 SHEET 3 AC 4 PHE A 241 PRO A 250 -1 O PHE A 241 N PHE A 208 SHEET 4 AC 4 ARG A 234 PRO A 235 -1 O ARG A 234 N GLN A 242 SHEET 1 AD 4 ASP A 223 GLN A 224 0 SHEET 2 AD 4 THR A 214 ARG A 219 -1 O TRP A 217 N GLN A 224 SHEET 3 AD 4 TYR A 257 GLN A 262 -1 O THR A 258 N GLN A 218 SHEET 4 AD 4 LEU A 270 ARG A 273 -1 O LEU A 270 N VAL A 261 SHEET 1 BA 4 LYS B 6 SER B 11 0 SHEET 2 BA 4 ASN B 21 PHE B 30 -1 O ASN B 24 N TYR B 10 SHEET 3 BA 4 PHE B 62 PHE B 70 -1 O PHE B 62 N PHE B 30 SHEET 4 BA 4 GLU B 50 HIS B 51 -1 O GLU B 50 N TYR B 67 SHEET 1 BB 4 LYS B 6 SER B 11 0 SHEET 2 BB 4 ASN B 21 PHE B 30 -1 O ASN B 24 N TYR B 10 SHEET 3 BB 4 PHE B 62 PHE B 70 -1 O PHE B 62 N PHE B 30 SHEET 4 BB 4 SER B 55 PHE B 56 -1 O SER B 55 N TYR B 63 SHEET 1 BC 4 GLU B 44 ARG B 45 0 SHEET 2 BC 4 ILE B 35 LYS B 41 -1 O LYS B 41 N GLU B 44 SHEET 3 BC 4 TYR B 78 HIS B 84 -1 O ALA B 79 N LEU B 40 SHEET 4 BC 4 LYS B 91 LYS B 94 -1 O LYS B 91 N VAL B 82 SHEET 1 EA 2 SER E 2 GLN E 5 0 SHEET 2 EA 2 CYS E 22 GLN E 25 -1 O THR E 23 N THR E 4 SHEET 1 EB 5 LEU E 9 THR E 13 0 SHEET 2 EB 5 THR E 110 VAL E 115 1 O SER E 111 N VAL E 10 SHEET 3 EB 5 LEU E 87 LEU E 96 -1 O TYR E 88 N THR E 110 SHEET 4 EB 5 LEU E 32 GLN E 37 -1 O PHE E 33 N ALA E 91 SHEET 5 EB 5 LYS E 44 LYS E 48 -1 O LYS E 44 N VAL E 36 SHEET 1 EC 4 LEU E 9 THR E 13 0 SHEET 2 EC 4 THR E 110 VAL E 115 1 O SER E 111 N VAL E 10 SHEET 3 EC 4 LEU E 87 LEU E 96 -1 O TYR E 88 N THR E 110 SHEET 4 EC 4 LYS E 103 PHE E 106 -1 O LYS E 103 N LEU E 96 SHEET 1 ED 3 VAL E 18 LEU E 20 0 SHEET 2 ED 3 LEU E 75 LYS E 77 -1 O LEU E 75 N LEU E 20 SHEET 3 ED 3 HIS E 63 ALA E 64 -1 O HIS E 63 N GLN E 76 SHEET 1 EE 7 ALA E 124 LYS E 129 0 SHEET 2 EE 7 THR E 139 THR E 144 -1 O LEU E 140 N LEU E 128 SHEET 3 EE 7 SER E 175 TRP E 183 -1 O ALA E 180 N PHE E 143 SHEET 4 EE 7 PHE E 161 ILE E 162 -1 O PHE E 161 N TRP E 183 SHEET 5 EE 7 SER E 175 TRP E 183 -1 O TRP E 183 N PHE E 161 SHEET 6 EE 7 THR E 166 MET E 170 -1 O THR E 166 N GLY E 179 SHEET 7 EE 7 SER E 175 TRP E 183 -1 O SER E 175 N MET E 170 SHEET 1 FA 4 VAL F 4 SER F 7 0 SHEET 2 FA 4 VAL F 19 GLN F 25 -1 O SER F 22 N SER F 7 SHEET 3 FA 4 SER F 76 LEU F 79 -1 O LEU F 77 N LEU F 21 SHEET 4 FA 4 LYS F 66 SER F 68 -1 O LYS F 66 N ILE F 78 SHEET 1 FB 9 SER F 10 VAL F 14 0 SHEET 2 FB 9 THR F 112 LEU F 116A 1 O ARG F 113 N LYS F 11 SHEET 3 FB 9 ALA F 88 SER F 95 -1 O ALA F 88 N LEU F 114 SHEET 4 FB 9 GLU F 56 LYS F 57 0 SHEET 5 FB 9 HIS F 41 SER F 49 -1 O TYR F 48 N GLU F 56 SHEET 6 FB 9 TYR F 31 ASP F 38 -1 O MET F 32 N SER F 49 SHEET 7 FB 9 ALA F 88 SER F 95 -1 O VAL F 89 N GLN F 37 SHEET 8 FB 9 TYR F 107 PHE F 108 -1 O TYR F 107 N SER F 94 SHEET 9 FB 9 ALA F 88 SER F 95 -1 O SER F 94 N TYR F 107 SHEET 1 FC 7 LYS F 126 PHE F 130 0 SHEET 2 FC 7 LYS F 142 PHE F 152 -1 O VAL F 146 N PHE F 130 SHEET 3 FC 7 SER F 189 SER F 199 -1 O TYR F 190 N PHE F 152 SHEET 4 FC 7 VAL F 172 THR F 174 -1 O SER F 173 N ARG F 195 SHEET 5 FC 7 SER F 189 SER F 199 -1 O ARG F 195 N SER F 173 SHEET 6 FC 7 TYR F 179 SER F 182 -1 O TYR F 179 N ALA F 191 SHEET 7 FC 7 SER F 189 SER F 199 -1 O SER F 189 N GLU F 181 SHEET 1 FD 4 LYS F 166 VAL F 168 0 SHEET 2 FD 4 VAL F 157 VAL F 163 -1 O TRP F 161 N VAL F 168 SHEET 3 FD 4 HIS F 209 PHE F 216 -1 O ARG F 211 N TRP F 162 SHEET 4 FD 4 GLN F 235 TRP F 242 -1 O GLN F 235 N PHE F 216 SHEET 1 HA 8 GLU H 46 PRO H 47 0 SHEET 2 HA 8 THR H 31 ASP H 37 -1 O ARG H 35 N GLU H 46 SHEET 3 HA 8 ARG H 21 VAL H 28 -1 O ALA H 24 N PHE H 36 SHEET 4 HA 8 HIS H 3 VAL H 12 -1 O ARG H 6 N TYR H 27 SHEET 5 HA 8 THR H 94 VAL H 103 -1 O VAL H 95 N SER H 11 SHEET 6 HA 8 PHE H 109 TYR H 118 -1 N LEU H 110 O ASP H 102 SHEET 7 HA 8 LYS H 121 LEU H 126 -1 O LYS H 121 N TYR H 118 SHEET 8 HA 8 TRP H 133 ALA H 135 -1 O THR H 134 N ALA H 125 SHEET 1 HB 7 LYS H 186 ALA H 193 0 SHEET 2 HB 7 GLU H 198 PHE H 208 -1 O THR H 200 N HIS H 192 SHEET 3 HB 7 PHE H 241 PRO H 250 -1 O PHE H 241 N PHE H 208 SHEET 4 HB 7 THR H 228 LEU H 230 -1 O GLU H 229 N ALA H 246 SHEET 5 HB 7 PHE H 241 PRO H 250 -1 O ALA H 246 N GLU H 229 SHEET 6 HB 7 ARG H 234 PRO H 235 -1 O ARG H 234 N GLN H 242 SHEET 7 HB 7 PHE H 241 PRO H 250 -1 O GLN H 242 N ARG H 234 SHEET 1 HC 4 GLU H 222 GLN H 224 0 SHEET 2 HC 4 THR H 214 ARG H 219 -1 O TRP H 217 N GLN H 224 SHEET 3 HC 4 TYR H 257 GLN H 262 -1 O THR H 258 N GLN H 218 SHEET 4 HC 4 LEU H 270 ARG H 273 -1 O LEU H 270 N VAL H 261 SHEET 1 IA 7 LYS I 6 SER I 11 0 SHEET 2 IA 7 ASN I 21 PHE I 30 -1 O ASN I 24 N TYR I 10 SHEET 3 IA 7 PHE I 62 PHE I 70 -1 O PHE I 62 N PHE I 30 SHEET 4 IA 7 GLU I 50 HIS I 51 -1 O GLU I 50 N TYR I 67 SHEET 5 IA 7 PHE I 62 PHE I 70 -1 O TYR I 67 N GLU I 50 SHEET 6 IA 7 SER I 55 PHE I 56 -1 O SER I 55 N TYR I 63 SHEET 7 IA 7 PHE I 62 PHE I 70 -1 O TYR I 63 N SER I 55 SHEET 1 IB 4 GLU I 44 ARG I 45 0 SHEET 2 IB 4 GLU I 36 LYS I 41 -1 O LYS I 41 N GLU I 44 SHEET 3 IB 4 TYR I 78 ASN I 83 -1 O ALA I 79 N LEU I 40 SHEET 4 IB 4 LYS I 91 LYS I 94 -1 O LYS I 91 N VAL I 82 SHEET 1 LA 2 SER L 2 GLN L 5 0 SHEET 2 LA 2 CYS L 22 GLN L 25 -1 O THR L 23 N THR L 4 SHEET 1 LB 8 LEU L 9 THR L 13 0 SHEET 2 LB 8 THR L 110 VAL L 115 1 O SER L 111 N VAL L 10 SHEET 3 LB 8 LEU L 87 LEU L 96 -1 O TYR L 88 N THR L 110 SHEET 4 LB 8 LYS L 44 LYS L 48 0 SHEET 5 LB 8 LEU L 32 GLN L 37 -1 O TRP L 34 N LEU L 46 SHEET 6 LB 8 LEU L 87 LEU L 96 -1 O LEU L 87 N GLN L 37 SHEET 7 LB 8 LYS L 103 PHE L 106 -1 O LYS L 103 N LEU L 96 SHEET 8 LB 8 LEU L 87 LEU L 96 -1 O LEU L 92 N VAL L 105 SHEET 1 LC 3 VAL L 18 LEU L 20 0 SHEET 2 LC 3 LEU L 75 LYS L 77 -1 O LEU L 75 N LEU L 20 SHEET 3 LC 3 HIS L 63 ALA L 64 -1 O HIS L 63 N GLN L 76 SHEET 1 LD 7 ALA L 124 LYS L 129 0 SHEET 2 LD 7 THR L 139 THR L 144 -1 O LEU L 140 N LEU L 128 SHEET 3 LD 7 SER L 175 TRP L 183 -1 O ALA L 180 N PHE L 143 SHEET 4 LD 7 PHE L 161 ILE L 162 -1 O PHE L 161 N TRP L 183 SHEET 5 LD 7 SER L 175 TRP L 183 -1 O TRP L 183 N PHE L 161 SHEET 6 LD 7 THR L 166 MET L 170 -1 O THR L 166 N GLY L 179 SHEET 7 LD 7 SER L 175 TRP L 183 -1 O SER L 175 N MET L 170 SHEET 1 MA 4 VAL M 4 SER M 7 0 SHEET 2 MA 4 VAL M 19 GLN M 25 -1 O SER M 22 N SER M 7 SHEET 3 MA 4 SER M 76 LEU M 79 -1 O LEU M 77 N LEU M 21 SHEET 4 MA 4 LYS M 66 SER M 68 -1 O LYS M 66 N ILE M 78 SHEET 1 MB 9 SER M 10 VAL M 14 0 SHEET 2 MB 9 THR M 112 LEU M 116A 1 O ARG M 113 N LYS M 11 SHEET 3 MB 9 ALA M 88 SER M 95 -1 O ALA M 88 N LEU M 114 SHEET 4 MB 9 GLU M 56 LYS M 57 0 SHEET 5 MB 9 HIS M 41 SER M 49 -1 O TYR M 48 N GLU M 56 SHEET 6 MB 9 TYR M 31 ASP M 38 -1 O MET M 32 N SER M 49 SHEET 7 MB 9 ALA M 88 SER M 95 -1 O VAL M 89 N GLN M 37 SHEET 8 MB 9 TYR M 107 PHE M 108 -1 O TYR M 107 N SER M 94 SHEET 9 MB 9 ALA M 88 SER M 95 -1 O SER M 94 N TYR M 107 SHEET 1 MC 7 LYS M 126 PHE M 130 0 SHEET 2 MC 7 LYS M 142 PHE M 152 -1 O VAL M 146 N PHE M 130 SHEET 3 MC 7 TYR M 190 SER M 199 -1 O TYR M 190 N PHE M 152 SHEET 4 MC 7 VAL M 172 THR M 174 -1 O SER M 173 N ARG M 195 SHEET 5 MC 7 TYR M 190 SER M 199 -1 O ARG M 195 N SER M 173 SHEET 6 MC 7 TYR M 179 LYS M 180 -1 O TYR M 179 N ALA M 191 SHEET 7 MC 7 TYR M 190 SER M 199 -1 O ALA M 191 N TYR M 179 SHEET 1 MD 4 LYS M 166 VAL M 168 0 SHEET 2 MD 4 VAL M 157 VAL M 163 -1 O TRP M 161 N VAL M 168 SHEET 3 MD 4 HIS M 209 PHE M 216 -1 O ARG M 211 N TRP M 162 SHEET 4 MD 4 GLN M 235 TRP M 242 -1 O GLN M 235 N PHE M 216 SSBOND 1 CYS A 101 CYS A 164 1555 1555 2.05 SSBOND 2 CYS A 203 CYS A 259 1555 1555 2.03 SSBOND 3 CYS B 25 CYS B 80 1555 1555 2.03 SSBOND 4 CYS E 22 CYS E 90 1555 1555 2.03 SSBOND 5 CYS E 141 CYS E 191 1555 1555 2.04 SSBOND 6 CYS F 23 CYS F 92 1555 1555 2.03 SSBOND 7 CYS F 147 CYS F 212 1555 1555 2.04 SSBOND 8 CYS H 101 CYS H 164 1555 1555 2.05 SSBOND 9 CYS H 203 CYS H 259 1555 1555 2.03 SSBOND 10 CYS I 25 CYS I 80 1555 1555 2.03 SSBOND 11 CYS L 22 CYS L 90 1555 1555 2.03 SSBOND 12 CYS L 141 CYS L 191 1555 1555 2.04 SSBOND 13 CYS M 23 CYS M 92 1555 1555 2.04 SSBOND 14 CYS M 147 CYS M 212 1555 1555 2.04 CISPEP 1 TYR A 209 PRO A 210 0 2.51 CISPEP 2 HIS B 31 PRO B 32 0 -0.22 CISPEP 3 SER F 7 PRO F 8 0 -1.70 CISPEP 4 PHE F 153 PRO F 154 0 -16.57 CISPEP 5 TYR H 209 PRO H 210 0 -1.83 CISPEP 6 HIS I 31 PRO I 32 0 3.75 CISPEP 7 SER M 7 PRO M 8 0 -2.72 CISPEP 8 PHE M 153 PRO M 154 0 -6.94 CRYST1 93.489 84.178 121.773 90.00 92.05 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010696 0.000000 0.000383 0.00000 SCALE2 0.000000 0.011880 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008217 0.00000